Alumis Inc. SEC filings ALMS
Alumis Inc. has 248 filings in SEC EDGAR's recent list, going back to Feb 25, 2021. Its latest annual report, Form ARS, was filed on May 18, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 1, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3ASR | Automatic shelf registration | Mar 19, 2026 | — |
| S-8 | Employee stock plan registration | Jan 30, 2026 | — |
| 424B5 | Prospectus supplement | Jan 8, 2026 | — |
| 424B5 | Prospectus supplement | Jan 6, 2026 | — |
| S-3 | Shelf registration | Jul 3, 2025 | — |
| S-8 | Employee stock plan registration | Jun 10, 2025 | — |
| 424B3 | Prospectus | Apr 23, 2025 | — |
| S-4 | Registration for a merger or exchange | Apr 21, 2025 | — |
| 424B3 | Prospectus | Apr 4, 2025 | — |
| S-4/A | Filing | Apr 2, 2025 | — |
| S-4 | Registration for a merger or exchange | Mar 27, 2025 | — |
| S-8 | Employee stock plan registration | Mar 19, 2025 | — |
| S-8 | Employee stock plan registration | Jul 1, 2024 | — |
| 424B4 | Prospectus | Jun 28, 2024 | — |
| FWP | Free writing prospectus | Jun 28, 2024 | — |
| S-1/A | Amended registration statement | Jun 24, 2024 | — |
| S-1/A | Amended registration statement | Jun 18, 2024 | — |
| S-1 | Registration statement | Jun 7, 2024 | — |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ALMS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1847367
- Former names
- FL2021-001, Inc. (until Mar 19, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.